Elevated expression of HSPA1A/HSP70 (a member of the HSPA family, an alternative name of HSP70 will be used throughout the paper) was correlated with poor prognosis and resistance to therapy in many human cancers [62–67]. Here, HSPA1A is linked to cancer.